info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Carcinoembryonic Antigen Companies

Carcinoembryonic antigen (CEA) companies focus on developing diagnostic tests and technologies for detecting CEA, a protein associated with certain cancers, particularly colorectal cancer. These companies contribute to oncology by providing assays and tools that aid in cancer screening, monitoring, and treatment decision-making.

Carcinoembryonic antigen (CEA) companies

 


Latest Carcinoembryonic antigen Companies Updates:


Dec 2024


Abbott Laboratories Launched their ARCHITECT® i1000SR immunoassay analyzer featuring a highly sensitive CEA assay, offering rapid and accurate detection of low-level CEA levels for early cancer detection.Partnered with healthcare institutions to implement their automated and efficient CEA testing solutions for improved patient care.


Roche Holding AG Expanded their cobas® elecsys immunoassay platform with a new, highly specific CEA test, minimizing interference from other factors and providing reliable results for cancer diagnosis and monitoring.Focused on developing integrated and automated laboratory solutions for efficient and seamless CEA testing workflows.


Siemens Healthineers Introduced their Atellica® IM immunoassay analyzer featuring a multi-parameter test cartridge including CEA, enabling simultaneous testing of various tumor markers for comprehensive cancer diagnosis.Emphasized their commitment to providing clinicians with comprehensive diagnostic tools for accurate cancer detection and management.


Bio-Rad Laboratories Developed new point-of-care CEA testing kits offering rapid and convenient testing options for clinicians and patients, potentially facilitating early cancer screening in resource-limited settings.Collaborated with public health organizations to improve access to CEA testing in underserved communities.


GenScript CorporationLaunched their ELISA-based CEA testing kits with high sensitivity and specificity, catering to research laboratories and diagnostic centers for accurate CEA level determination.Focused on providing affordable and reliable tools for CEA research and clinical applications.


List of Carcinoembryonic antigen Key companies in the market



  • Lee BioSolutions

  • F. Hoffmann-La Roche

  • Quest Diagnostics Incorporated

  • Genway Biotech

  • RayBiotech

  • Merck KGaA

  • Abcam plc

  • Boster Biological Technology

  • Creative Diagnostics

  • Laboratory Corporation of America Holdings



 

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.